Bacteriostatic Water in Compounded GLP-1s: What It Is and Why It's There
If you've looked at the label on your compounded semaglutide vial, you've probably seen "bacteriostatic water" or "bacteriostatic sodium chloride" listed among the ingredients. You may also have noticed "benzyl alcohol 0.9%" somewhere in the formulation. These aren't active ingredients — they're the vehicle and preservative system that keeps your multi-dose vial safe to use over multiple withdrawals.
What Bacteriostatic Water Is
Bacteriostatic water for injection (abbreviated BAC water or BWFI) is sterile water that contains 0.9% benzyl alcohol as a preservative. The "bacteriostatic" label means it inhibits the growth of bacteria — it doesn't kill bacteria that are already present (that would be "bactericidal"), but it prevents new bacterial contamination from multiplying after the vial is opened.
This distinction matters for multi-dose vials. Every time you puncture the rubber stopper with a needle, you create a tiny pathway for bacteria to enter the vial. In a preservative-free solution, any bacteria that enters can multiply freely, potentially reaching dangerous levels within hours. In a solution preserved with bacteriostatic water, the benzyl alcohol suppresses bacterial growth, extending the safe-use window from hours to weeks.
Why Multi-Dose Vials Need Preservation
Most compounded GLP-1 prescriptions come in multi-dose vials — a single vial contains enough medication for multiple weekly injections (typically 4-8 weeks of doses in one vial, depending on the concentration and prescription). Each injection requires a new needle puncture through the stopper. Without a bacteriostatic preservative:
- USP <797> limits multi-dose vial use to 28 days after first puncture even with preservative — and 24 hours without preservative.
- A preservative-free multi-dose vial would need to be discarded after a single day of use, wasting the remaining doses.
- The risk of injection site infections increases with every draw from a preservative-free vial.
Bacteriostatic water solves this problem by providing a preservative system that maintains microbial safety across the vial's use period. It's the same preservative system used in millions of insulin multi-dose vials worldwide — a proven, well-understood technology.
What Benzyl Alcohol Does
Benzyl alcohol at 0.9% concentration (9 mg/mL) works as a preservative by disrupting bacterial cell membranes, preventing bacteria from growing and reproducing in the solution. At this concentration, it's effective against a broad spectrum of bacteria commonly encountered in pharmaceutical environments.
Safety Profile
Benzyl alcohol at 0.9% has a long safety track record in injectable medications. It's classified as "generally recognized as safe" (GRAS) by the FDA for use in injectable products at preservative concentrations. The amounts administered in a typical GLP-1 injection — a fraction of a milliliter — deliver a negligible dose of benzyl alcohol relative to the body's capacity to metabolize it.
Who Should Be Aware
Two populations warrant specific mention:
- Neonates (premature and low-birth-weight infants): Benzyl alcohol has been associated with serious adverse events in neonates, including "gasping syndrome." GLP-1 medications are not prescribed to neonates, so this is not a practical concern for GLP-1 patients — but it's the reason you'll see a neonatal warning on benzyl alcohol product labels.
- Benzyl alcohol allergy: True allergy to benzyl alcohol is rare but documented. Patients with a known benzyl alcohol allergy should inform their prescriber and pharmacy. Preservative-free formulations (using sterile water for injection instead of bacteriostatic water) can be compounded, though they require single-use vials or more frequent compounding.
Even with bacteriostatic water, USP <797> limits multi-dose vial use to 28 days after first puncture. Mark the date of your first injection on the vial. After 28 days, discard the vial even if medication remains — the preservative system's ability to suppress contamination diminishes over time and repeated punctures.
Bacteriostatic Water vs. Sterile Water
These two products are not interchangeable despite their similar appearance:
- Bacteriostatic water for injection (BWFI): Sterile water + 0.9% benzyl alcohol. Suitable for multi-dose vials. 28-day use window after first entry.
- Sterile water for injection (SWFI): Pure sterile water with no preservative. Suitable for single-use preparations only. Must be used immediately and discarded — any remainder is not safe for later use.
If your pharmacy ships a lyophilized (freeze-dried) product with a vial of reconstitution water, check the label to confirm whether it's bacteriostatic or sterile water. If it's sterile water, the reconstituted product must be used within 24 hours unless the pharmacy's labeling specifies otherwise with supporting stability data.
The Role of Bacteriostatic Sodium Chloride
Some compounded GLP-1 formulations use bacteriostatic sodium chloride (0.9% NaCl with 0.9% benzyl alcohol) instead of bacteriostatic water. The added sodium chloride makes the solution isotonic — matching the salt concentration of body fluids. Isotonic solutions can reduce injection site discomfort compared to hypotonic (pure water-based) solutions, particularly for larger injection volumes.
Both vehicles are acceptable for compounded GLP-1 preparations. The choice between them typically reflects the pharmacy's formulation preference rather than a clinically significant difference for the patient.
Storage After First Use
Once you've drawn your first dose from a multi-dose vial preserved with bacteriostatic water:
- Store the vial refrigerated (2-8°C / 36-46°F)
- Do not freeze — freezing can damage both the peptide and the preservative system
- Keep the vial upright with the stopper facing up
- Clean the stopper with an alcohol swab before every use
- Use a new syringe and needle for every draw — never leave a needle in the stopper
- Discard after 28 days or at the beyond-use date, whichever comes first
Providers Using Quality-Preserved Formulations
Embody
Injectable semaglutide through established 503A pharmacy partnerships. Clinician-monitored dosing with direct pharmacy fulfillment.
Compounded medications are not FDA-approved.
Learn More Paid linkOak Health
GLP-1 weight loss program with pharmacy-direct fulfillment and provider consultations included.
Compounded medications are not FDA-approved.
Learn More Paid linkAgeless
GLP-1 weight loss plans with provider oversight and pharmacy fulfillment included.
Compounded medications are not FDA-approved.
Learn More Paid linkCompare GLP-1 Providers Side by Side
See pricing, pharmacy credentials, and delivery formats for verified telehealth providers.
View Provider Comparison →Sources
- USP. "General Chapter <797> — Multi-Dose Container Use and Beyond-Use Dating." Revised November 2023.
- FDA. "Inactive Ingredient Database — Benzyl Alcohol." Updated 2025.
- Nema, S., Brendel, R.J. "Excipient Interaction with Preservative Effectiveness in Parenteral Formulations." PDA Journal of Pharmaceutical Science and Technology. 2023.
- CDC. "Safe Injection Practices: Multi-Dose Vial Use." Updated 2024.
Affiliate Disclosure: Some links on this page are paid affiliate links. If you sign up through them, we may earn a commission at no extra cost to you. This does not influence our editorial content or provider evaluations.
Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) carry FDA approval for their indicated uses.